HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 06-MAR-14 4P38 TITLE HUMAN 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN COMPLEX WITH TITLE 2 AZD8329 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CORTICOSTEROID 11-BETA-DEHYDROGENASE ISOZYME 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,11-BETA-HSD1; COMPND 5 EC: 1.1.1.146; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSD11B1, HSD11, HSD11L; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALPHA BETA, ROSSMANN FOLD, NADP, OXIDOREDUCTASE-OXIDOREDUCTASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.OGG,D.HARGREAVES,S.GERHARDT REVDAT 3 01-NOV-17 4P38 1 SOURCE JRNL REMARK REVDAT 2 12-NOV-14 4P38 1 KEYWDS REVDAT 1 30-APR-14 4P38 0 JRNL AUTH J.S.SCOTT,J.DESCHOOLMEESTER,E.KILGOUR,R.M.MAYERS,M.J.PACKER, JRNL AUTH 2 D.HARGREAVES,S.GERHARDT,D.J.OGG,A.REES,N.SELMI,A.STOCKER, JRNL AUTH 3 J.G.SWALES,P.R.WHITTAMORE JRNL TITL NOVEL ACIDIC 11 BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 (11 JRNL TITL 2 BETA-HSD1) INHIBITOR WITH REDUCED ACYL GLUCURONIDE JRNL TITL 3 LIABILITY: THE DISCOVERY OF JRNL TITL 4 4-[4-(2-ADAMANTYLCARBAMOYL) JRNL TITL 5 -5-TERT-BUTYL-PYRAZOL-1-YL]BENZOIC ACID (AZD8329). JRNL REF J.MED.CHEM. V. 55 10136 2012 JRNL REFN ISSN 1520-4804 JRNL PMID 23088558 JRNL DOI 10.1021/JM301252N REMARK 0 REMARK 0 THIS IS A PDBCHK OUTPUT, CREATED THU OCT 18 11:43:16 2012 ON REMARK 0 HOST: UKAPDWLX049. ORIGINAL FILE: /XTAL/WORK/BHSD/AZ12782812/ REMARK 0 DEPOSIT/BHSD-AZ12782812_FI REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 20763 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 1062 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.95 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.68 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2986 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2794 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2840 REMARK 3 BIN R VALUE (WORKING SET) : 0.2776 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.89 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4068 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 160 REMARK 3 SOLVENT ATOMS : 29 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 103.6 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 75.53 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.92910 REMARK 3 B22 (A**2) : -8.92910 REMARK 3 B33 (A**2) : 17.85810 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.505 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.668 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.340 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.682 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.346 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.932 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4323 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5873 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1501 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 81 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 666 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4323 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 568 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5144 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.27 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.01 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.13 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -13.0786 65.2825 30.4737 REMARK 3 T TENSOR REMARK 3 T11: -0.1326 T22: -0.1709 REMARK 3 T33: -0.1187 T12: -0.0446 REMARK 3 T13: 0.0091 T23: 0.0303 REMARK 3 L TENSOR REMARK 3 L11: 1.4228 L22: 1.7259 REMARK 3 L33: 3.1992 L12: 0.0283 REMARK 3 L13: 0.1467 L23: -0.6526 REMARK 3 S TENSOR REMARK 3 S11: 0.0176 S12: 0.0307 S13: 0.2523 REMARK 3 S21: 0.0503 S22: 0.0086 S23: -0.0052 REMARK 3 S31: -0.5638 S32: -0.1337 S33: -0.0262 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): -4.3013 38.1247 38.8979 REMARK 3 T TENSOR REMARK 3 T11: -0.1175 T22: -0.1336 REMARK 3 T33: -0.1738 T12: -0.0358 REMARK 3 T13: -0.0835 T23: 0.0031 REMARK 3 L TENSOR REMARK 3 L11: 1.2478 L22: 2.0845 REMARK 3 L33: 3.0682 L12: -0.2791 REMARK 3 L13: 0.7561 L23: -0.4082 REMARK 3 S TENSOR REMARK 3 S11: 0.1063 S12: -0.0373 S13: -0.2163 REMARK 3 S21: -0.0940 S22: 0.0245 S23: -0.0233 REMARK 3 S31: 0.7063 S32: 0.2255 S33: -0.1308 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4P38 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000200614. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.514 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.9L REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20969 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 30.270 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.11100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.54000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 42% PEG400, 100 MM TRIS-HCL PH 8.5 AND REMARK 280 2 MM COMPOUND, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.92667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 89.85333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 89.85333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 44.92667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: GEL FILTRATION CONFIRMS THE DIMERIZATION OF THE PROTEIN IN REMARK 300 SOLUTION REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20570 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -91.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 19400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38730 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -202.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 44.92667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY B 229 REMARK 465 ILE B 290 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 288 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 290 CG1 CG2 CD1 REMARK 470 ILE B 230 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 65 177.86 178.27 REMARK 500 ASN A 119 -31.30 -130.30 REMARK 500 HIS A 130 -67.59 -126.79 REMARK 500 PHE A 144 -65.06 -122.49 REMARK 500 SER A 169 -158.43 -109.47 REMARK 500 LYS A 174 -34.19 -131.44 REMARK 500 LEU A 179 -1.74 74.84 REMARK 500 ARG A 288 32.25 -84.06 REMARK 500 PHE A 289 -34.45 -133.02 REMARK 500 ALA B 65 179.40 178.35 REMARK 500 ASN B 119 -32.72 -130.74 REMARK 500 HIS B 130 -66.99 -126.55 REMARK 500 PHE B 144 -66.13 -122.39 REMARK 500 SER B 169 -158.03 -108.64 REMARK 500 LYS B 174 -33.25 -130.74 REMARK 500 LEU B 179 -1.66 72.82 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NDP A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 21T A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NDP B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 21T B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HFR RELATED DB: PDB REMARK 900 4HFR CONTAINS THE SAME PROTEIN COMPLEXED TO ANOTHER LIGAND DBREF 4P38 A 26 290 UNP P28845 DHI1_HUMAN 26 290 DBREF 4P38 B 26 290 UNP P28845 DHI1_HUMAN 26 290 SEQADV 4P38 LEU A 179 UNP P28845 MET 179 CONFLICT SEQADV 4P38 ARG A 262 UNP P28845 LEU 262 CONFLICT SEQADV 4P38 SER A 272 UNP P28845 CYS 272 CONFLICT SEQADV 4P38 GLU A 278 UNP P28845 PHE 278 CONFLICT SEQADV 4P38 TRP A 286 UNP P28845 MET 286 CONFLICT SEQADV 4P38 LEU B 179 UNP P28845 MET 179 CONFLICT SEQADV 4P38 ARG B 262 UNP P28845 LEU 262 CONFLICT SEQADV 4P38 SER B 272 UNP P28845 CYS 272 CONFLICT SEQADV 4P38 GLU B 278 UNP P28845 PHE 278 CONFLICT SEQADV 4P38 TRP B 286 UNP P28845 MET 286 CONFLICT SEQRES 1 A 265 GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS VAL ILE SEQRES 2 A 265 VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU MET ALA SEQRES 3 A 265 TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL VAL THR SEQRES 4 A 265 ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SER HIS SEQRES 5 A 265 CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR ILE ALA SEQRES 6 A 265 GLY THR MET GLU ASP MET THR PHE ALA GLU GLN PHE VAL SEQRES 7 A 265 ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP MET LEU SEQRES 8 A 265 ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN LEU PHE SEQRES 9 A 265 HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET GLU VAL SEQRES 10 A 265 ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA ALA LEU SEQRES 11 A 265 PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL VAL VAL SEQRES 12 A 265 SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU VAL ALA SEQRES 13 A 265 ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY PHE PHE SEQRES 14 A 265 SER SER ILE ARG LYS GLU TYR SER VAL SER ARG VAL ASN SEQRES 15 A 265 VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE ASP THR SEQRES 16 A 265 GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL HIS MET SEQRES 17 A 265 GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU ILE ILE SEQRES 18 A 265 LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR TYR ASP SEQRES 19 A 265 SER SER ARG TRP THR THR LEU LEU ILE ARG ASN PRO SER SEQRES 20 A 265 ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER TYR ASN SEQRES 21 A 265 TRP ASP ARG PHE ILE SEQRES 1 B 265 GLU PHE ARG PRO GLU MET LEU GLN GLY LYS LYS VAL ILE SEQRES 2 B 265 VAL THR GLY ALA SER LYS GLY ILE GLY ARG GLU MET ALA SEQRES 3 B 265 TYR HIS LEU ALA LYS MET GLY ALA HIS VAL VAL VAL THR SEQRES 4 B 265 ALA ARG SER LYS GLU THR LEU GLN LYS VAL VAL SER HIS SEQRES 5 B 265 CYS LEU GLU LEU GLY ALA ALA SER ALA HIS TYR ILE ALA SEQRES 6 B 265 GLY THR MET GLU ASP MET THR PHE ALA GLU GLN PHE VAL SEQRES 7 B 265 ALA GLN ALA GLY LYS LEU MET GLY GLY LEU ASP MET LEU SEQRES 8 B 265 ILE LEU ASN HIS ILE THR ASN THR SER LEU ASN LEU PHE SEQRES 9 B 265 HIS ASP ASP ILE HIS HIS VAL ARG LYS SER MET GLU VAL SEQRES 10 B 265 ASN PHE LEU SER TYR VAL VAL LEU THR VAL ALA ALA LEU SEQRES 11 B 265 PRO MET LEU LYS GLN SER ASN GLY SER ILE VAL VAL VAL SEQRES 12 B 265 SER SER LEU ALA GLY LYS VAL ALA TYR PRO LEU VAL ALA SEQRES 13 B 265 ALA TYR SER ALA SER LYS PHE ALA LEU ASP GLY PHE PHE SEQRES 14 B 265 SER SER ILE ARG LYS GLU TYR SER VAL SER ARG VAL ASN SEQRES 15 B 265 VAL SER ILE THR LEU CYS VAL LEU GLY LEU ILE ASP THR SEQRES 16 B 265 GLU THR ALA MET LYS ALA VAL SER GLY ILE VAL HIS MET SEQRES 17 B 265 GLN ALA ALA PRO LYS GLU GLU CYS ALA LEU GLU ILE ILE SEQRES 18 B 265 LYS GLY GLY ALA LEU ARG GLN GLU GLU VAL TYR TYR ASP SEQRES 19 B 265 SER SER ARG TRP THR THR LEU LEU ILE ARG ASN PRO SER SEQRES 20 B 265 ARG LYS ILE LEU GLU GLU LEU TYR SER THR SER TYR ASN SEQRES 21 B 265 TRP ASP ARG PHE ILE HET NDP A 301 48 HET 21T A 302 31 HET CL A 303 1 HET NDP B 301 48 HET 21T B 302 31 HET CL B 303 1 HETNAM NDP NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 2 NDP PHOSPHATE HETNAM 21T 4-[4-(2-ADAMANTYLCARBAMOYL)-5-TERT-BUTYL-PYRAZOL-1- HETNAM 2 21T YL]BENZOIC ACID HETNAM CL CHLORIDE ION FORMUL 3 NDP 2(C21 H30 N7 O17 P3) FORMUL 4 21T 2(C25 H31 N3 O3) FORMUL 5 CL 2(CL 1-) FORMUL 9 HOH *29(H2 O) HELIX 1 AA1 ARG A 28 GLN A 33 5 6 HELIX 2 AA2 LYS A 44 MET A 57 1 14 HELIX 3 AA3 SER A 67 GLY A 82 1 16 HELIX 4 AA4 ASP A 95 GLY A 111 1 17 HELIX 5 AA5 ASP A 132 PHE A 144 1 13 HELIX 6 AA6 PHE A 144 SER A 161 1 18 HELIX 7 AA7 ALA A 172 LYS A 174 5 3 HELIX 8 AA8 VAL A 180 SER A 204 1 25 HELIX 9 AA9 THR A 220 SER A 228 1 9 HELIX 10 AB1 PRO A 237 LEU A 251 1 15 HELIX 11 AB2 SER A 261 ARG A 269 1 9 HELIX 12 AB3 ASN A 270 TYR A 284 1 15 HELIX 13 AB4 ARG B 28 GLN B 33 5 6 HELIX 14 AB5 LYS B 44 MET B 57 1 14 HELIX 15 AB6 SER B 67 GLY B 82 1 16 HELIX 16 AB7 ASP B 95 GLY B 111 1 17 HELIX 17 AB8 ASP B 132 PHE B 144 1 13 HELIX 18 AB9 PHE B 144 GLN B 160 1 17 HELIX 19 AC1 ALA B 172 LYS B 174 5 3 HELIX 20 AC2 VAL B 180 SER B 204 1 25 HELIX 21 AC3 THR B 220 SER B 228 1 9 HELIX 22 AC4 PRO B 237 LEU B 251 1 15 HELIX 23 AC5 SER B 261 ARG B 269 1 9 HELIX 24 AC6 ASN B 270 TYR B 284 1 15 SHEET 1 AA1 7 SER A 85 TYR A 88 0 SHEET 2 AA1 7 HIS A 60 VAL A 63 1 N VAL A 61 O SER A 85 SHEET 3 AA1 7 LYS A 36 VAL A 39 1 N VAL A 37 O HIS A 60 SHEET 4 AA1 7 MET A 115 LEU A 118 1 O ILE A 117 N ILE A 38 SHEET 5 AA1 7 SER A 164 SER A 170 1 O VAL A 166 N LEU A 116 SHEET 6 AA1 7 SER A 209 LEU A 215 1 O THR A 211 N VAL A 167 SHEET 7 AA1 7 GLU A 255 TYR A 258 1 O VAL A 256 N VAL A 214 SHEET 1 AA2 7 SER B 85 TYR B 88 0 SHEET 2 AA2 7 HIS B 60 THR B 64 1 N VAL B 61 O SER B 85 SHEET 3 AA2 7 LYS B 36 THR B 40 1 N VAL B 37 O HIS B 60 SHEET 4 AA2 7 MET B 115 LEU B 118 1 O ILE B 117 N ILE B 38 SHEET 5 AA2 7 SER B 164 SER B 170 1 O VAL B 166 N LEU B 116 SHEET 6 AA2 7 SER B 209 LEU B 215 1 O THR B 211 N VAL B 167 SHEET 7 AA2 7 GLU B 255 TYR B 258 1 O VAL B 256 N VAL B 214 SITE 1 AC1 26 GLY A 41 ALA A 42 SER A 43 LYS A 44 SITE 2 AC1 26 GLY A 45 ILE A 46 ALA A 65 ARG A 66 SITE 3 AC1 26 SER A 67 THR A 92 MET A 93 ASN A 119 SITE 4 AC1 26 ILE A 121 VAL A 168 SER A 169 SER A 170 SITE 5 AC1 26 TYR A 183 LYS A 187 LEU A 215 GLY A 216 SITE 6 AC1 26 LEU A 217 ILE A 218 THR A 220 THR A 222 SITE 7 AC1 26 ALA A 223 21T A 302 SITE 1 AC2 11 LEU A 126 SER A 170 LEU A 171 TYR A 183 SITE 2 AC2 11 LEU A 215 GLY A 216 LEU A 217 ALA A 223 SITE 3 AC2 11 NDP A 301 TYR B 280 TYR B 284 SITE 1 AC3 4 GLY A 45 ARG A 48 GLU A 221 LYS A 238 SITE 1 AC4 30 GLY B 41 ALA B 42 SER B 43 LYS B 44 SITE 2 AC4 30 GLY B 45 ILE B 46 ALA B 65 ARG B 66 SITE 3 AC4 30 SER B 67 THR B 92 MET B 93 ASN B 119 SITE 4 AC4 30 HIS B 120 ILE B 121 VAL B 168 SER B 169 SITE 5 AC4 30 SER B 170 TYR B 183 LYS B 187 LEU B 215 SITE 6 AC4 30 GLY B 216 LEU B 217 ILE B 218 THR B 220 SITE 7 AC4 30 THR B 222 ALA B 223 21T B 302 HOH B 402 SITE 8 AC4 30 HOH B 405 HOH B 406 SITE 1 AC5 10 TYR A 280 TYR A 284 SER B 170 LEU B 171 SITE 2 AC5 10 TYR B 177 TYR B 183 LEU B 215 GLY B 216 SITE 3 AC5 10 LEU B 217 NDP B 301 SITE 1 AC6 4 GLY B 45 GLU B 221 LYS B 238 HOH B 406 CRYST1 103.516 103.516 134.780 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009660 0.005577 0.000000 0.00000 SCALE2 0.000000 0.011155 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007419 0.00000 MASTER 356 0 6 24 14 0 23 6 0 0 0 42 END